These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 30146736)

  • 1. Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway.
    Zeng Z; Zhou W; Duan L; Zhang J; Lu X; Jin L; Yu Y
    J Cell Physiol; 2019 Apr; 234(4):3887-3896. PubMed ID: 30146736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.
    Liu H; Chen D; Bi J; Han J; Yang M; Dong W; Lin T; Huang J
    Aging (Albany NY); 2018 Oct; 10(10):2606-2623. PubMed ID: 30312173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
    Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
    J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.
    Yang D; Qian H; Fang Z; Xu A; Zhao S; Liu B; Li D
    Cancer Med; 2020 Jan; 9(2):700-710. PubMed ID: 31758655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G
    J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.
    Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X; Zhao S
    Mol Oncol; 2021 Feb; 15(2):697-709. PubMed ID: 33244865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p/IGF2R regulation.
    Zhang Z; Mou Z; Xu C; Wu S; Dai X; Chen X; Ou Y; Chen Y; Yang C; Jiang H
    Cell Death Dis; 2021 Aug; 12(8):778. PubMed ID: 34365465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circ_0000515 adsorbs miR-542-3p to accelerate bladder cancer progression via up-regulating ILK expression.
    Peng G; Guan J; Leng P; Peng L; Cao M; Feng Y
    Aging (Albany NY); 2022 Jan; 14(1):430-442. PubMed ID: 35029589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
    Chen L; Yang X; Zhao J; Xiong M; Almaraihah R; Chen Z; Hou T
    J Exp Clin Cancer Res; 2020 May; 39(1):94. PubMed ID: 32460831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circ_100984-miR-432-3p axis regulated c-Jun/YBX-1/β-catenin feedback loop promotes bladder cancer progression.
    Tong L; Yang H; Xiong W; Tang G; Zu X; Qi L
    Cancer Sci; 2021 Apr; 112(4):1429-1442. PubMed ID: 33314480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis.
    Yao J; Zhang C; Chen Y; Gao S
    Life Sci; 2019 Dec; 239():116871. PubMed ID: 31521692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
    Shi Y; Liu C
    BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.
    Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J
    Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive circular RNA profiling reveals the regulatory role of the hsa_circ_0137606/miR‑1231 pathway in bladder cancer progression.
    Li W; Li Y; Sun Z; Zhou J; Cao Y; Ma W; Xie K; Yan X
    Int J Mol Med; 2019 Nov; 44(5):1719-1728. PubMed ID: 31545480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
    Bi J; Liu H; Dong W; Xie W; He Q; Cai Z; Huang J; Lin T
    Mol Cancer; 2019 Sep; 18(1):133. PubMed ID: 31481066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed circ_0067934 acts as an oncogene to facilitate cervical cancer progression via the miR-545/EIF3C axis.
    Hu C; Wang Y; Li A; Zhang J; Xue F; Zhu L
    J Cell Physiol; 2019 Jun; 234(6):9225-9232. PubMed ID: 30362562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA hsa_circ_0001368 suppresses the progression of gastric cancer by regulating miR-6506-5p/FOXO3 axis.
    Lu J; Zhang PY; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Huang CM; Zheng CH
    Biochem Biophys Res Commun; 2019 Apr; 512(1):29-33. PubMed ID: 30853185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.